Donghee Han1, Rhanderson Cordoso2, Seamus Whelton2, Alan Rozanski3, Matthew J Budoff4, Michael D Miedema5, Khurram Nasir6, Leslee J Shaw7, John A Rumberger8, Heidi Gransar1, Zeina Dardari2, Roger S Blumenthal2, Michael J Blaha2, Daniel S Berman1. 1. Department of Imaging, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA. 2. Department of Medicine, Division of Cardiology, Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Johns Hopkins University, Baltimore, MD, USA. 3. Division of Cardiology, Mount Sinai St. Luke's Hospital, New York, NY, USA. 4. Department of Medicine, Harbor-UCLA Medical Center, University of California Los Angeles, Los Angeles, CA, USA. 5. Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, MN, USA. 6. Division Cardiovascular Prevention and Wellness, Houston Methodist Hospital, Houston, TX, USA. 7. Department of Radiology, Weill Cornell Medicine, New York, NY, USA. 8. Princeton Longevity Center, Princeton, NJ, USA.
Abstract
AIMS: Aortic valve calcification (AVC) has been shown to be associated with increased cardiovascular disease (CVD) risk; however, whether this is independent of traditional risk factors and coronary artery calcification (CAC) remains unclear. METHODS AND RESULTS: From the multicentre CAC Consortium database, 10 007 patients (mean 55.8±11.7 years, 64% male) with concomitant CAC and AVC scoring were included in the current analysis. AVC score was quantified using the Agatston score method and categorized as 0, 1-99, and ≥100. The endpoints were all-cause, CVD, and coronary heart disease (CHD) deaths. AVC (AVC>0) was observed in 1397 (14%) patients. During a median 7.8 (interquartile range: 4.7-10.6) years of study follow-up, 511 (5.1%) deaths occurred; 179 (35%) were CVD deaths, and 101 (19.8%) were CHD deaths. A significant interaction between CAC and AVC for mortality was observed (P<0.001). The incidence of mortality events increased with higher AVC; however, AVC ≥100 was not independently associated with all-cause, CVD, and CHD deaths after adjusting for CVD risk factors and CAC (P=0.192, 0.063, and 0.206, respectively). When further stratified by CAC<100 or ≥100, AVC ≥100 was an independent predictor of all-cause and CVD deaths only in patients with CAC <100, after adjusting for CVD risk factors and CAC [hazard ratio (HR): 1.93, 95% confidence interval (CI): 1.14-3.27; P=0.013 and HR: 2.71, 95% CI: 1.15-6.34; P=0.022, respectively]. CONCLUSION: Although the overall prognostic significance of AVC was attenuated after accounting for CAC, high AVC was independently associated with all-cause and CVD deaths in patients with low coronary atherosclerosis burden. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Aortic valve calcification (AVC) has been shown to be associated with increased cardiovascular disease (CVD) risk; however, whether this is independent of traditional risk factors and coronary artery calcification (CAC) remains unclear. METHODS AND RESULTS: From the multicentre CAC Consortium database, 10 007 patients (mean 55.8±11.7 years, 64% male) with concomitant CAC and AVC scoring were included in the current analysis. AVC score was quantified using the Agatston score method and categorized as 0, 1-99, and ≥100. The endpoints were all-cause, CVD, and coronary heart disease (CHD) deaths. AVC (AVC>0) was observed in 1397 (14%) patients. During a median 7.8 (interquartile range: 4.7-10.6) years of study follow-up, 511 (5.1%) deaths occurred; 179 (35%) were CVD deaths, and 101 (19.8%) were CHD deaths. A significant interaction between CAC and AVC for mortality was observed (P<0.001). The incidence of mortality events increased with higher AVC; however, AVC ≥100 was not independently associated with all-cause, CVD, and CHD deaths after adjusting for CVD risk factors and CAC (P=0.192, 0.063, and 0.206, respectively). When further stratified by CAC<100 or ≥100, AVC ≥100 was an independent predictor of all-cause and CVD deaths only in patients with CAC <100, after adjusting for CVD risk factors and CAC [hazard ratio (HR): 1.93, 95% confidence interval (CI): 1.14-3.27; P=0.013 and HR: 2.71, 95% CI: 1.15-6.34; P=0.022, respectively]. CONCLUSION: Although the overall prognostic significance of AVC was attenuated after accounting for CAC, high AVC was independently associated with all-cause and CVD deaths in patients with low coronary atherosclerosis burden. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Matthew J Budoff; Songshou Mao; Junichiro Takasu; David M Shavelle; Xue-Qiao Zhao; Kevin D O'Brien Journal: Acad Radiol Date: 2002-10 Impact factor: 3.173
Authors: Harvey S Hecht; Michael J Blaha; Ella A Kazerooni; Ricardo C Cury; Matt Budoff; Jonathon Leipsic; Leslee Shaw Journal: J Cardiovasc Comput Tomogr Date: 2018-03-30
Authors: B F Stewart; D Siscovick; B K Lind; J M Gardin; J S Gottdiener; V E Smith; D W Kitzman; C M Otto Journal: J Am Coll Cardiol Date: 1997-03-01 Impact factor: 24.094
Authors: Michael J Blaha; Matthew J Budoff; Juan J Rivera; Atif N Khan; Raul D Santos; Leslee J Shaw; Paolo Raggi; Daniel Berman; John A Rumberger; Roger S Blumenthal; Khurram Nasir Journal: Am J Cardiol Date: 2010-11-04 Impact factor: 2.778
Authors: David Messika-Zeitoun; Lawrence F Bielak; Patricia A Peyser; Patrick F Sheedy; Stephen T Turner; Vuyisile T Nkomo; Jerome F Breen; Joseph Maalouf; Christopher Scott; A Jamil Tajik; Maurice Enriquez-Sarano Journal: Arterioscler Thromb Vasc Biol Date: 2006-12-21 Impact factor: 8.311
Authors: David S Owens; Matthew J Budoff; Ronit Katz; Junichiro Takasu; David M Shavelle; J Jeffrey Carr; Susan R Heckbert; Catherine M Otto; Jeffrey L Probstfield; Richard A Kronmal; Kevin D O'Brien Journal: JACC Cardiovasc Imaging Date: 2012-06
Authors: Tania Pawade; Marie-Annick Clavel; Christophe Tribouilloy; Julien Dreyfus; Tiffany Mathieu; Lionel Tastet; Cedric Renard; Mesut Gun; William Steven Arthur Jenkins; Laurent Macron; Jacob W Sechrist; Joan M Lacomis; Virginia Nguyen; Laura Galian Gay; Hug Cuéllar Calabria; Ioannis Ntalas; Timothy Robert Graham Cartlidge; Bernard Prendergast; Ronak Rajani; Arturo Evangelista; João L Cavalcante; David E Newby; Philippe Pibarot; David Messika Zeitoun; Marc R Dweck Journal: Circ Cardiovasc Imaging Date: 2018-03 Impact factor: 7.792
Authors: David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson Journal: J Am Coll Cardiol Date: 2013-11-12 Impact factor: 24.094
Authors: Miguel Cainzos-Achirica; Isaac Acquah; Zeina Dardari; Reed Mszar; Philip Greenland; Ron Blankstein; Marcio Bittencourt; Sanjay Rajagopalan; Sadeer G Al-Kindi; Joseph F Polak; Roger S Blumenthal; Michael J Blaha; Khurram Nasir Journal: Am J Cardiol Date: 2021-12-15 Impact factor: 2.778
Authors: Tom Kai Ming Wang; Scott D Flamm; Paul Schoenhagen; Brian P Griffin; L Leonardo Rodriguez; Richard A Grimm; Bo Xu Journal: Radiol Cardiothorac Imaging Date: 2021-08-26
Authors: Alexander C Razavi; Rhanderson Cardoso; Omar Dzaye; Matthew Budoff; George Thanassoulis; Wendy S Post; Sanjiv Shah; Daniel S Berman; Khurram Nasir; Michael J Blaha; Seamus P Whelton Journal: Am J Cardiol Date: 2021-07-27 Impact factor: 3.133